Mulshine JL - Search Results

1

Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression.

Tockman MS, Mulshine JL, Piantadosi S, Erozan YS, Gupta PK, Ruckdeschel JC, Taylor PR, Zhukov T, Zhou WH, Qiao YL, Yao SX. Tockman MS, et al. Among authors: mulshine jl. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2237-46. Clin Cancer Res. 1997. PMID: 9815620

2

Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: a new approach to early lung cancer detection.

Tockman MS, Gupta PK, Myers JD, Frost JK, Baylin SB, Gold EB, Chase AM, Wilkinson PH, Mulshine JL. Tockman MS, et al. Among authors: mulshine jl. J Clin Oncol. 1988 Nov;6(11):1685-93. doi: 10.1200/JCO.1988.6.11.1685. J Clin Oncol. 1988. PMID: 2846790

3

The early detection of second primary lung cancers by sputum immunostaining. LCEWDG Investigators. Lung Cancer Early Detection Group.

Tockman MS, Erozan YS, Gupta P, Piantadosi S, Mulshine JL, Ruckdeschel JC. Tockman MS, et al. Among authors: mulshine jl. Chest. 1994 Dec;106(6 Suppl):385S-390S. doi: 10.1378/chest.106.6_supplement.385s. Chest. 1994. PMID: 7988270

4

Cytometric validation of immunocytochemical observations in developing lung cancer.

Tockman MS, Gupta PK, Pressman NJ, Mulshine JL. Tockman MS, et al. Among authors: mulshine jl. Diagn Cytopathol. 1993 Dec;9(6):615-22. doi: 10.1002/dc.2840090604. Diagn Cytopathol. 1993. PMID: 8143533

5

Considerations in developing successful, population-based molecular screening and prevention of lung cancer.

Mulshine JL, De Luca LM, Dedrick RL, Tockman MS, Webster R, Placke ME. Mulshine JL, et al. Cancer. 2000 Dec 1;89(11 Suppl):2465-7. doi: 10.1002/1097-0142(20001201)89:11+<2465::aid-cncr24>3.3.co;2-y. Cancer. 2000. PMID: 11147628 Review.

6

Considerations in bringing a cancer biomarker to clinical application.

Tockman MS, Gupta PK, Pressman NJ, Mulshine JL. Tockman MS, et al. Among authors: mulshine jl. Cancer Res. 1992 May 1;52(9 Suppl):2711s-2718s. Cancer Res. 1992. PMID: 1563002 Review.

7

Diagnostic research: breakout group report.

Mulshine JL, Tockman MS. Mulshine JL, et al. Cancer Res. 1992 May 1;52(9 Suppl):2766s. Cancer Res. 1992. PMID: 1563010 No abstract available.

8

High frequency of K-ras codon 12 mutations in bronchoalveolar lavage fluid of patients at high risk for second primary lung cancer.

Scott FM, Modali R, Lehman TA, Seddon M, Kelly K, Dempsey EC, Wilson V, Tockman MS, Mulshine JL. Scott FM, et al. Among authors: mulshine jl. Clin Cancer Res. 1997 Mar;3(3):479-82. Clin Cancer Res. 1997. PMID: 9815708

9

The early detection of occult lung cancer.

Tockman MS, Mulshine JL. Tockman MS, et al. Among authors: mulshine jl. Chest Surg Clin N Am. 2000 Nov;10(4):737-49. Chest Surg Clin N Am. 2000. PMID: 11091923 Review.

10

Expression of early lung cancer detection marker: hnRNP-A2/B1 and its relation to microsatellite alteration in non-small cell lung cancer.

Zhou J, Nong L, Wloch M, Cantor A, Mulshine JL, Tockman MS. Zhou J, et al. Among authors: mulshine jl. Lung Cancer. 2001 Dec;34(3):341-50. doi: 10.1016/s0169-5002(01)00254-9. Lung Cancer. 2001. PMID: 11714531

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

211 results

Search Page